March 2010

DMA established a Preferred Drug List (PDL) on March 15, 2010 to obtian better prices for covered outpatient drugs through supplemental rebates. Initially, there will be NO changes in the drugs that are currently covered.  In the future, selected therapeutic drug classes will be reviewed and specific drugs defined as "preferred." Generally, these drugs will not require Prior Authorization(PA) unless there are other clinical PA requirements such as step therapy or quantity limits.

"Non-preferred" drugs will be available if prior authorization criteria are met.  The PA process will be the same as it is today.  The prescriber will be responsible for initiating a PA request.  For therapeutic drug classes that do not appear on the PDL, nothing has changed.